Medication info
Pitasan Tablet 2mg (Pitavastatin Calcium Hydrate)

Pitasan Tablet 2mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›2.205mg / 1 tablet
Manufacturer / importer
GL Pharma Co., Ltd.
Appearance
Very pale yellow-red round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202003208 · Approved 2020.04.29 · Insurance code 649702690

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
GL Pharma Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • apolipoprotein B
  • triglyceride levels
View approved original text

This medicine is used as an adjunct to diet in patients with primary hypercholesterolemia and mixed dyslipidemia to lower total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels, while increasing HDL cholesterol, the good cholesterol. It helps improve blood lipid levels and enhance cardiovascular health.

How to take

Adult dose

Before and during treatment with this medicine, patients must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be administered to certain patients. For example, it should not be used in patients who are allergic to any ingredient of this medication, have active liver disease, or consistently high liver enzyme levels of unknown cause, severe liver dysfunction, cholestasis, patients taking cyclosporine, those with myopathy, women who are pregnant or may become pregnant, nursing mothers, and there is no experience in administering it to children. Additionally, patients with renal impairment or a history of liver dysfunction, patients who consume excessive amounts of alcohol, individuals taking certain medications (such as fibrates or nicotinic acid), patients with hypothyroidism or genetic muscle diseases or a history of muscle-related conditions, elderly patients, and those with severe muscle weakness should use this medication with caution. This medication may have various adverse reactions including muscle pain, weakness, liver function abnormalities, skin rash, itching, and gastrointestinal disturbances. In particular, rhabdomyolysis, a condition in which muscle tissue is damaged, can occur, so if there is severe muscle pain or weakness, use should be discontinued immediately. Regular liver function tests should be performed before and during treatment to monitor for any liver dysfunction, and blood lipid levels should be evaluated periodically to assess treatment effectiveness. Since this medication is primarily metabolized in the liver, the dosage should be reduced in patients with liver dysfunction, and due to multiple drug interactions, especially when combined with cyclosporine or fibrates, the risk of rhabdomyolysis and renal function deterioration is high, so such combinations should be avoided or closely monitored. Elderly patients may experience adverse reactions more readily due to diminished physiological function; therefore, caution is advised during administration. Pregnant and nursing mothers should avoid this medication due to potential risks to the fetus or newborn, and if pregnancy is confirmed, the medication should be discontinued immediately. Children are not to be used as safety and efficacy have not been established. Finally, this medication should be stored out of reach of children and kept in its original container to prevent misuse or deterioration of quality.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • numbness
  • itching
  • myalgia
  • weakness
  • elevated CPK level
  • increased myoglobin in blood and urine
  • acute renal failure
Show 97 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • feeling of heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • loss of strength
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid level
  • increased serum potassium and phosphorus
  • taste disturbances
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • sleep disorders
  • loss of appetite
  • elevated blood pressure
  • discomfort in the chest
  • weakness
  • abdominal pain
  • dyspepsia
  • thirst
  • constipation
  • nausea
  • increased γ-GT
  • increased LDH
  • increased ALP
  • itching
  • urticaria
  • thrombocytopenia
  • increased serum creatinine
  • increased BUN
  • elevated blood pressure
  • skin tingling
  • discomfort in the chest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a special container that does not allow light to enter. It is also safe to store the medication at cool room temperature, that is, between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Very pale yellow-red round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.